KIM, Dong Yeon,김동연,KANG, Soung Young,강성영,KIM, Yong Sun,김용선,CHOI, Eun Kyoung,최은경,CHOI, Yeong Gon,최영곤,PARK, Jeong Ho,박정호,SHIN, Jae Soo,신재수,CHO, Dae Jin,조대진,LEE, Gong Yeal,이공열,KIM, Hong Youb,김홍엽,LEE, Hea
申请号：
KRKR2019/008279
公开号：
WO2020/009522A1
申请日:
2019.07.05
申请国别(地区):
KR
年份:
2020
代理人:
摘要：
The present invention relates to a pharmaceutical composition for the prevention or treatment of a prion disease which is one of the neurodegenerative diseases, the composition comprising, as an active ingredient, radotinib or a pharmaceutically acceptable salt thereof.La présente invention concerne une composition pharmaceutique destinée à prévenir ou à traiter une maladie à prion, qui est l'une des maladies neurodégénératives, la composition comprenant en tant que principe actif du radotinib ou un sel pharmaceutiquement acceptable de celui-ci.본 발명은 라도티닙(Radotinib) 또는 그의 약제학적으로 허용 가능한 염을 유효성분으로 포함하는, 신경퇴행성 질환중의 하나인 프리온 질환의 예방 또는 치료를 위한 약제학적 조성물에 관한 것이다.
